| Literature DB >> 23028810 |
Christopher R Sudfeld1, Wafaie W Fawzi, Chandrakant Lahariya.
Abstract
OBJECTIVE: To examine the effect of peer support on duration of exclusive breastfeeding (EBF) in low and middle-income countries (LMICs). DATA SOURCES: Medline, EMBASE, and Cochrane Central Register for Controlled Trials were searched from inception to April 2012.Entities:
Mesh:
Year: 2012 PMID: 23028810 PMCID: PMC3445598 DOI: 10.1371/journal.pone.0045143
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Flow diagram of included and excluded studies.
Characteristics and results of included trials.
| Trial | Location | Area | Study population | Intervention definition | Training | Comparison | EBF Assessment | Effect on Exclusive Breastfeeding | Child Health Outcomes |
| Agrasada (2005)33 | Manila, Philippines | Urban | First-time mothers intending to breastfeed a low birth weight (<2500 g) singleton born between 37 and 42 wks | Home visits at days 3–5, 7–10, 21, 1.5 mo followed by monthly visits up to 5.5 month post-delivery. | 40 hours of training from certified lactation counselor | 1) No Support 2) Childcare support | Hospital interviews at 2 weeks, 4 weeks, and then monthly until 6 months | a) EBF 2 wk to 6 mo: PC 6.3 (3.53–11.3) times more likely to be exclusively fed at any time point [GEE analysis] b) EBF birth to 6 months: PC 32%, childcare group 3% and control 0% | a)No difference mean weight for age z-scores at 6 months. b) Decreased diarrhea in PC group (15%) vs. childcare (28.3%) and control (30.5%) |
| Aksu (2011)40 | Aydın, Turkey | Urban | Singleton healthy infant ≥37 weeks. <2500 g, Apgar ≤7, congenital anomalies excluded. | Home visit 3 days after birth. | 18-hour WHO/UNICEF breastfeeding support course | 20–30 min. breastfeeding education from nurses | Household interviews at 2 weeks, 6 weeks, and at 6 months | a) EBF at 6 months: PC 43% and comp. 23% b) EBF at 6 weeks: PC 60% and comp. 33% c) EBF at 2 weeks: PC 67% and comp. 40% | |
| Arifeen (2009)41 | Matlab, Bangladesh | Urban | Pregnant women in 20 government health facilities | IMCI home visits with village health workers and community nutrition promoters. | IMCI 2-day training course for feeding practices | Standard of care | Household census but method not directly stated | EBF 0–6 months: PC 76% and comp. 65% | a) U5 mortality rate was lower in IMCI than comp. areas (not significant ) |
| Coutinho (2005)34 | Pernambuco, Brazil | Urban | Singleton infants >2500 g without congenital anomalies or serious illness | Home visits on days 3, 7, 15, and 30, and then every 2 weeks during the 2nd month and once a month 3rd to 6th months. | 20 hour WHO Breastfeeding Support course | Hospital-based intervention only (BFHI) | Household interviews at 10, 30, 60, 90, 120, 150, and 180 days | EBF at 6 months: PC 24% and comp. 3% | |
| Davies-Adetugbo (1997)42 | Osun State, Nigeria | Rural | Mothers-infant pairs presenting to health facility for diarrhea. | Promoting EBF to 6 months of life at presentation to primary care clinic (day 0) and then on days 2 and 7 at home. | Adapted WHO/UNICEF 18-hour breastfeeding course | Standard of care | Home visit 7 and 21 by same peer supporters | a) EBF at day 21: PC 46% and comp. 8% b) EBF at day 7: PC 59% and comp. 6% (p<0.00001) | New episode of diarrhea by 21 days: PC 12% and comparison 22% (not significant) |
| Haider (2000)27 | Dhaka, Bangladesh | Urban | Women aged 16–35 years excluded infants with weight <1.8 kg, or congenital anomalies | Visits at 48 h of delivery, one on day 5, one during days 10–14, and every two weeks for 2–5 months. | 40 hours WHO breastfeeding support and King’s book | Routine Care | Household interviews at 72 hrs then monthly to 6 months | EBF at 6 months- PC 70% and comp. 6% (p<0·0001) | |
| Feldens (2007)35 | Sao Leopoldo, Brazil | Urban | Singleton, full-term infant with >2500 g | Home visits within 10 days of birth and monthly up to 6 months | 10 steps for feeding healthy infants’ +16 hours practicum | Routine assistance by pediatricians | Home visit at 6 and 12 months | a) EBF at 4 months: PC 35% and comp. 16% b) EBF at 1 month: PC 69% and comp. 49% | Decrease in odds of dental caries: OR 0.52 (0.27–0.97) |
| Jakobsen (1999)43 | Bandim, Guinea Bissau | Mix | Registered pregnancies in Bandim health project | Advised EBF for 4–5 months at routine local health centre visits at 6, 10 and 14 weeks. | NA | Routine Care | Weekly Household interviews | a) EBF at 4 months: PC 4.1% and comp. 3.7%; RR 1.08 (0.69–1.46) | |
| Leite (2005)36 | Fortaleza, Brazil | Urban | Singletonhealth infant | Home visits on the 5th day, 15th, 30th, 60th, 90th and 120th days. | 20 hrs Breastfeeding support: a training course | Routine Care | Household interviews at days 30 and 180 | a) EBF at 4 months: PC 25% and comp. 19% (p = .044) | |
| Morrow (1999)44 | San Pedro Martir, Mexico | Peri-urban | All pregnant women residing in the study area | 1) 6 visit group: Mid and late pregnancy and weeks 1, 2, 4, and 8. 2) 3 visit group: late pregnancy, and week 1 and 2. | 1 week classroom, 2 months in lactation clinics, and 6 months practice | Standard of care with no home-visits | Household interviews at 2, 4, and 6 weeks and at 2, 3 and 6 months | a)EBF at 3 months: 6 PC visits 67%, 3 PC visits 62%, and comparison 12%. b) Significantly more EBF overtime in PC groups vs controls p<0.0001 [GEE analysis] | Control infants significantly higher incidence of diarrhea to 3 months RR: 2.1 (90% CI: 1.11–4.04; p = 0.029) |
| Tylleskär (2011)37 | Banfora, Burkina Faso | Rural | Singleton births without severe malformation | Home visits during the third trimesters and weeks 2, 4, 8, 16, and 20. | 1 week WHO Breastfeeding support, HIV and Infant feeding crse. | Standard of care with no home-visits | Household interviews at 3 and 6 months | a) EBF at 6 months: i) 7-day recall -RR 7.53 (4.42–12.82) ii) 24-h recall -RR 3.33 (1.74–6.38)b) EBF at 3 months: i) 7-day recall - RR 3.27 (2.13–5.03) ii) 24-h recall RR 2.29 (1.33–3.92) | a) Diarrhea prevalence at 6 months by 2-week recall: PR - 0.83 (95% CI: 0.45–1.54) |
| Tylleskär (2011)37 | Mbale District, Uganda | Rural | Singleton births without severe malformation | Home visits during the third trimester, within the first week, and then weeks 4, 7, and 10. | 1 week WHO Breastfeeding support, HIV and Infant feeding crse. | Standard of care with no home-visits | Household interviews at 3 and 6 months | a) EBF at 6 months: i) 7-day recall - RR 4.66 (3.35–6.49) ii) 24-h recall :RR 3.83 (2.97–4.95) b) EBF at 3 months: i) 7-day recall - RR 2.30 (2.00–2.65) ii) 24-h recall RR 1.89 (1.70–2.11) | a) Diarrhea prevalence at 6 months by 2-week recall: PR - 0.82 (95% CI: 0.58–1.15) |
| Tylleskär (2011)37 | Paarl, Umlazi & Rietvlei, South Africa | Peri-urban and Rural | Singleton births without severe malformation | Home visits during the third trimester, within the first week, and then weeks 4, 7, and 10. | 1 week WHO Breastfeeding support, HIV and Infant feeding crse. | Standard of care with no home-visits | Household interviews at 3 and 6 months | a) EBF at 6 months: i) 7-day recall - RR 9.83 (1.40–69.14) ii) 24-h recall -RR 5.7 (1.33–24.26) b) EBF at 3 months: i) 7-day recall - RR 1.98 (1.30–3.02) ii)24-h recall -RR 1.72 (1.12–2.63) | a) Diarrhea prevalence at 6 months by 2-week recall: PR 1.31 (95% CI: 0.89–1.93) |
Figure 2Pooled relative risk and 95% confidence intervals for the effect of peer support on discontinuing EBF.
*Results from multicenter Tylleskär trial reported seperately. BF: Burkina Faso, SA: South Africa, UG: Uganda.
Results of univariate and multivariate random-effects metaregression.
| Variable | No. Trial Sites | Relative Risk(95% CI) | I2 | Univariatedifference inlog RR (95% CI) | p-value | Multivariatedifference inlog RR (95% CI) | p-value |
|
| |||||||
| Moderate to High (>10%) | 5 [33, 34, 35, 36, 37) | 0.84 (0.74–0.95) | 90% | 0.59 (0.15–1.03) | 0.016 | 0.59 (0.01–1.17) | 0.048 |
| Low (<10%) | 3 | 0.46 (0.36–0.59) | 32% | Ref. | – | Ref. | – |
|
| |||||||
| Yes | 2 | 0.73 (0.43–1.21) | 94% | 0.12 (−0.67–0.90) | 0.729 | −.21 (−0.78–0.36) | 0.367 |
| No | 6 | 0.67 (0.55–0.83) | 93% | Ref. | – | Ref. | – |
|
| |||||||
| 4 months | 2 | 0.92 (0.86–0.98) | 3% | 0.39 (−0.28–1.05) | 0.204 | 0.19 (−0.37–0.76) | 0.398 |
| 6 months | 6 | 0.61 (0.48–0.78) | 94% | Ref. | – | Ref. | – |
Results of each study site for multicenter Tylleskär trial reported separately.